Employees: NN (None)Legal category: 5485Size: NoneCreation date: 2015-07-16 (10 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: ANTIBES (06600), Alpes-Maritimes
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SELARL PHARMACIE GIMBERT : revenue, balance sheet and financial ratios
SELARL PHARMACIE GIMBERT is a French company
founded 10 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in ANTIBES (06600),
this company of category PME
shows in 2022 a net income positive of 94 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELARL PHARMACIE GIMBERT (SIREN 812610160)
Indicator
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
93 920 €
68 954 €
80 043 €
38 274 €
71 386 €
59 029 €
42 581 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2022, SELARL PHARMACIE GIMBERT generates positive net income of 94 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2022: 43 k€ -> 94 k€.
Net income (2022)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
93 920 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 153%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 36%. The balance between equity and debt is satisfactory.
Debt ratio (2022)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
152.581%
Financial autonomy (2022)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
Debt ratio
1904.275
925.232
522.465
408.184
296.542
208.809
152.581
Financial autonomy
4.484
8.679
14.634
17.299
21.897
28.202
35.765
Repayment capacity
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
152.582022
2020
2021
2022
Q1: 24.52
Med: 74.72
Q3: 182.51
Average-7 pts over 3 years
In 2022, the debt ratio of SELARL PHARMACIE GIMBERT (152.58) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
35.77%2022
2020
2021
2022
Q1: 28.54%
Med: 47.06%
Q3: 66.61%
Average+10 pts over 3 years
In 2022, the financial autonomy of SELARL PHARMACIE GIMBERT (35.8%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 998.13. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2022)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
Liquidity ratio
201.539
183.853
199.31
153.317
157.29
183.843
998.129
Interest coverage
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
998.132022
2020
2021
2022
Q1: 145.17
Med: 199.48
Q3: 274.99
Excellent+38 pts over 3 years
In 2022, the liquidity ratio of SELARL PHARMACIE GIMBERT (998.13) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Positioning of SELARL PHARMACIE GIMBERT in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 215 transactions of similar company sales
in 2022,
the value of SELARL PHARMACIE GIMBERT is estimated at
1 105 110 €
(range 742 853€ - 1 657 460€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2022
215 transactions
742k€1105k€1657k€
1 105 110 €Range: 742 853€ - 1 657 460€
NAF 5 année 2022
Valuation method used
Net Income Multiple
93 920 €
×
11.8x
=1 105 110 €
Range: 742 854€ - 1 657 461€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 215 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELARL PHARMACIE GIMBERT with other companies in the same sector:
Frequently asked questions about SELARL PHARMACIE GIMBERT
What is the revenue of SELARL PHARMACIE GIMBERT ?
The revenue of SELARL PHARMACIE GIMBERT is not publicly disclosed (confidential accounts filed with INPI).
Is SELARL PHARMACIE GIMBERT profitable?
Yes, SELARL PHARMACIE GIMBERT generated a net profit of 94 k€ in 2022.
Where is the headquarters of SELARL PHARMACIE GIMBERT ?
The headquarters of SELARL PHARMACIE GIMBERT is located in ANTIBES (06600), in the department Alpes-Maritimes.
Where to find the tax return of SELARL PHARMACIE GIMBERT ?
The tax return of SELARL PHARMACIE GIMBERT is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELARL PHARMACIE GIMBERT operate?
SELARL PHARMACIE GIMBERT operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart